Alegeus Appoints Industry Veteran Jackie Kosecoff to its Board of Directors

WALTHAM, Mass. — Alegeus, the market leader in consumer funding technology, today announced it has named Jacqueline Kosecoff to its Board of Directors, effective immediately. Kosecoff’s appointment reinforces the Alegeus market leadership position and ongoing commitment to enhancing its platform and value proposition.

Kosecoff joins the board as the company gears up for its next phase of growth – establishing itself as the number-one white-label technology provider in the consumer funding space, delivering a best-in-industry HSA experience, and scaling its operations for the rapid growth of its client base, which serves millions of consumers and processes billions of dollars of consumer healthcare payments annually.

Dr. Kosecoff is a seasoned corporate executive and board member with special depth of knowledge in health services and technology. She helped found and lead private equity-backed companies, including Value Health Sciences and Protocare. She went on to serve as Executive Vice President of PacifiCare and CEO of OptumRx at UnitedHealth Group.

Currently, Dr. Kosecoff is working in private equity to identify, select, mentor and manage health companies. She also sits on the board of directors of public companies, including Alignment Healthcare, GoodRx, Houlihan Lokey, STERIS plc and TriNet Group.

We’re thrilled to welcome Jackie as a member of our Board of Directors,” said Leif O’Leary, Alegeus CEO. “Her exceptional track record as a customer-focused growth leader in the healthcare technology industry will be instrumental as we continue to unlock the potential of the consumer funding space.
Alegeus is uniquely positioned in one of the fastest growing segments of healthcare, with a flexible, industry-leading platform and an impressive customer base with massive reach in the marketplace,” Kosecoff said. “I’m excited to bring my experience and perspective to the board of directors and executive team to help take this company to the next level.

Dr. Kosecoff holds a BA from the University of California, Los Angeles (UCLA), an MS in Applied Mathematics from Brown University, and a doctorate from UCLA.

About Alegeus

With more than 25 years of growth and innovation, Alegeus is the market leader in SaaS-based healthcare payment solutions. Our highly flexible, white-label platform powers account-based benefit programs such as HSAs, FSAs, HRAs, COBRA, wellness incentives, lifestyle benefits and beyond. We deliver exceptional user experiences and differentiated capabilities that help our partners strengthen their product offerings, operate more efficiently, and unlock their full growth potential. Our partnerships with the industry’s leading health plans, third-party administrators, financial services and benefit solution providers give Alegeus unparalleled reach in the market. And our unique partnership model empowers our clients to achieve outsized results – growing their programs at a rate that is 2-3X the market, and with the highest net promoter scores (NPS) in the industry. We never compete with our clients – we win when they win. Alegeus is headquartered in Waltham, Mass., with operations centers in Orlando and Bangalore, and a large remote workforce.

Sign up for our newsletter

Alegeus Announces Recipients of 2024 APEX Awards for Partner Excellence

Top Five Reasons to Attend the Alegeus Partner Success Summit

IRS Reminder: Companies misrepresenting nutrition, wellness and general health expenses as medical care for FSAs, HSAs and HRAs

Alegeus Earns Important New Patent Grants

Alegeus Selected for BenefitsPRO’s 2023 LUMINARIES Award

Alegeus Earns 2023 Great Place To Work® Certification

New Alegeus Research Highlights In-Demand Benefits

Alegeus Sees Continued Momentum for its Market-Leading COBRA Platform

Alegeus Leaders Named to CRN’s 2023 Women of the Channel

Alegeus Announces Recipients of 2023 APEX Awards for Partner Excellence

New Alegeus Research Finds Many Laid-Off Employees are Unfamiliar with Continuation of Health Coverage

Alegeus Appoints Melanie Hallenbeck as Chief Growth Officer